The global competent cells market size was valued at USD 2.24 billion in 2024 and is expected to reach USD 4.85 Billion by 2032, at a CAGR of 10.11% during the forecast period
The market growth is largely fueled by the expanding field of molecular biology and genetic engineering, where competent cells are essential tools for gene cloning, protein expression, and transformation protocols
Furthermore, rising research activities in drug development, synthetic biology, and personalized medicine are increasing the demand for high-efficiency competent cells across academic, pharmaceutical, and biotechnology sectors. These converging factors are accelerating the uptake of competent cell solutions, thereby significantly boosting the industry's growth